Bibliothèque

Geographic distribution of conversion therapy prevalence in Canada. Findings from a national cross-sectional survey, 2020.

BACKGROUND: Conversion therapy practices (CTPs) are discredited efforts that target lesbian, gay, bisexual, trans, queer, Two-Spirit, or other (LGBTQ2S+) people and seek to change, deny, or discourage…

Thérapies de Conversion

Tiwana, A., Salway, T., Schillaci-Ventura, J., & Watt, S. (2023). Geographic distribution of conversion therapy prevalence in Canada. Findings from a national cross-sectional survey, 2020.. F1000Res, 12, 844. https://doi.org/10.12688/f1000research.134292.2

01/01/2023 Lire →

Conversion Surgery After Encorafenib Plus Cetuximab for Chemorefractory V600E-mutated Colorectal Cancer With Para-aortic Lymph Node Metastases.

BACKGROUND/AIM: Mutant BRAF V600E colorectal cancer accounts for 5% of metastatic colorectal cancers, and it has a poor response to systemic chemotherapy and a poor prognosis. However, combination tre…

Thérapies de Conversion

Kawata, A., Miyamoto, Y., Fukubayashi, K., Horio, T., Miyamoto, H., Ogawa, K., Ouchi, M., Tanaka, Y., & Baba, H. (2023). Conversion Surgery After Encorafenib Plus Cetuximab for Chemorefractory V600E-mutated Colorectal Cancer With Para-aortic Lymph Node Metastases.. In Vivo, 37(4), 1797-1801. https://doi.org/10.21873/invivo.13269

01/01/2023 Lire →

Safety and efficacy of laparoscopic digestive tract nutrition reconstruction combined with conversion therapy for patients with unresectable and obstructive gastric cancer.

BACKGROUND: To explore the safety, efficacy, and survival benefits of laparoscopic digestive tract nutrition reconstruction (LDTNR) combined with conversion therapy in patients with unresectable gastr…

Thérapies de Conversion

Ye, R., Wang, C., Hu, B., & Guan, G. (2023). Safety and efficacy of laparoscopic digestive tract nutrition reconstruction combined with conversion therapy for patients with unresectable and obstructive gastric cancer.. Front Oncol, 13, 1175580. https://doi.org/10.3389/fonc.2023.1175580

01/01/2023 Lire →

The role of F-FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy.

PURPOSE: To investigate the diagnostic value of F-fluorodeoxyglucose positron emission tomography (F-FDG PET), as an imaging biomarker, for predicting pathological response and prognosis of unresectab…

Thérapies de Conversion

Wang, G., Zhang, W., Luan, X., Wang, Z., Liu, J., Xu, X., Zhang, J., Xu, B., Lu, S., Wang, R., & Ma, G. (2023). The role of F-FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy.. Front Immunol, 14, 1151967. https://doi.org/10.3389/fimmu.2023.1151967

01/01/2023 Lire →

Gender and sexuality in mental health: perspectives on lesbians, gays, bisexuals, and transgender (LGBT) rights and mental health in the ASEAN region.

This perspective piece focuses on and analyzes several lesbians, gays, bisexuals, and transgender (LGBT) individuals' rights and their limitations in the Association of Southeast Asian Nations (ASEAN)…

Thérapies de Conversion

Alibudbud, R. (2023). Gender and sexuality in mental health: perspectives on lesbians, gays, bisexuals, and transgender (LGBT) rights and mental health in the ASEAN region.. Front Sociol, 8, 1174488. https://doi.org/10.3389/fsoc.2023.1174488

01/01/2023 Lire →

Conversion therapy for advanced hepatocellular carcinoma with vascular invasion: a comprehensive review.

Hepatocellular carcinoma (HCC) is the most common type of liver cancer and has a high mortality rate worldwide. The percentage of HCC patients with vascular invasion at the time of initial HCC diagnos…

Thérapies de Conversion

Zhang, Z., & Zhang, E. (2023). Conversion therapy for advanced hepatocellular carcinoma with vascular invasion: a comprehensive review.. Front Immunol, 14, 1073531. https://doi.org/10.3389/fimmu.2023.1073531

01/01/2023 Lire →

Case report: A ERBB3 mutation develops in a gallbladder cancer patient carrying BRCA1 mutation after effective treatment with olaparib.

BACKGROUND: Gallbladder cancer (GBC) is highly lethal and resistant to most chemotherapeutic drugs. GBC was reported to carry multiple genetic mutations such as TP53, K-RAS, and ERBB2/3. Here, we unex…

Thérapies de Conversion

Yang, J. X., Jia, Z. Y., Liu, F. T., Wu, W. G., Li, X. C., Zou, L., Li, H. F., Zhang, F., Bao, R. F., Peng, S. Y., Lau, W. Y., Liu, Y., Li, M. L., & Liu, Y. B. (2023). Case report: A ERBB3 mutation develops in a gallbladder cancer patient carrying BRCA1 mutation after effective treatment with olaparib.. Front Oncol, 13, 1078388. https://doi.org/10.3389/fonc.2023.1078388

01/01/2023 Lire →

Evolving jurisprudence on conversion therapy: Reconsidering ethics in mental health systems.

Since the Delhi High Court judgement (2009), reading down IPC 377 that criminalised homosexuality, the Indian judiciary has been at the forefront of invoking constitutional morality to uphold LGBTQIA+…

Thérapies de Conversion

Kottai, S. R., & Ramprakash, R. (2023). Evolving jurisprudence on conversion therapy: Reconsidering ethics in mental health systems.. Indian J Med Ethics, VIII(4), 296-302. https://doi.org/10.20529/IJME.2023.024

01/01/2023 Lire →